Translated automatically – community improvements welcome.
Noxiron
Methylprylon is a sedative pyrazolone derivative that was primarily used as a tranquilizer and sleep aid. It acts by modulating the GABA-A receptor and leads to central nervous system depression. Due to its potential for dependence and toxic effects, it has been withdrawn from the market in many countries. The substance can lead to severe side effects in case of overdose.
Mechanism of Action
- GABA-A Modulation
Names / Identifiers
IUPAC: Methylprylon
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Pregnancy
- Liver diseases
- Respiratory diseases
Known Risks
- medium
- Methylprylon kann Abhängigkeitspotenzial und toxische Wirkungen aufweisen.
Safer Use
- Start at a low dose.
- Avoid polydrug use with other sedating substances.
Harm reduction tips do not replace medical advice.
Known Interactions
- Alcohol
- Benzodiazepines
- Opioids
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.